{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:42:07Z","timestamp":1770133327095,"version":"3.49.0"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T00:00:00Z","timestamp":1162944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasmablastic lymphoma is an aggressive subtype of diffuse large B\u2010cell lymphoma that is mainly observed in patients with the human immunodeficiency virus (HIV) infection, and it tends to arise in the oral cavity. We present a case of an HIV\u2010infected patient with plasmablastic lymphoma with prolonged survival. The 30\u2010yr\u2010old woman was found to have an oral lesion at the time of the diagnosis of HIV infection. Histological and immunochemical examination of biopsy of the oral lesion showed plasmablastic lymphoma (CD138+). She received two cycles of cyclophosphamide, vincristine, doxorubicin, and prednisolone (CHOP) that started 10 weeks after the initiation of antiretroviral therapy. The continuing pancytopenia and an adenoviral febrile infection did not permit further antineoplastic treatment. A gradual decrease of the oral lesion was noted after the second cycle of chemotherapy that led to the disappearance of the lesion 7 months later. The patient remains in complete remission 61 months after the diagnosis of plasmablastic lymphoma. Am. J. Hematol., 2007. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20807","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T20:17:03Z","timestamp":1163017023000},"page":"761-765","source":"Crossref","is-referenced-by-count":25,"title":["Prolonged survival of an HIV\u2010infected patient with plasmablastic lymphoma of the oral cavity"],"prefix":"10.1002","volume":"82","author":[{"given":"George","family":"Panos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymia A.","family":"Karveli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ourania","family":"Nikolatou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,8]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Lymphoma Foundation of Canada (LFC). Available at www.lymphoma.ca\/hiv_lymphoma.htm. (accessed on May 20 2006)."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80514-5"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80169-3_4"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(89)90416-1"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400007789"},{"key":"e_1_2_1_7_2","first-page":"1337","article-title":"Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection","volume":"90","author":"Delecluse HJ","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290006260"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh399"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001697395"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348949910800115"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(99)70170-8"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(98)80089-7"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(01)00018-5"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.9355"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408303110904"},{"key":"e_1_2_1_17_2","first-page":"480","article-title":"Human immunodeficiency virus\u2010associated Hodgkin's disease","volume":"27","author":"Spina M","year":"2000","journal-title":"Semin Oncol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1309\/PNVQ0PQGXHVY6L7G"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-4-309"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011201)92:11<2739::AID-CNCR10121>3.0.CO;2-E"},{"key":"e_1_2_1_21_2","unstructured":"US National Institutes of Health US National Cancer Institute. Available at www.cancer.gov\/cancertopics\/pdq\/treatment\/AIDS\u2010related\u2010lymphoma\/healthprofessional (accessed on January 30 2006)."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-005-0062-5"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3857"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200108170-00005"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.195"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.093"},{"key":"e_1_2_1_28_2","first-page":"2171","article-title":"Chemotherapy for human immunodeficiency virus\u2010associated non\u2010Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner L","year":"2001","journal-title":"Clin Oncol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1437"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00024"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70664-7"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200206140-00021"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.23.2220"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199715000-00022"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20807","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:07:58Z","timestamp":1700078878000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1002\/ajh.20807"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20807","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,8]]}}}